[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356284-105":59,"doc-detail-356284-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","molecular-analysis-based-on-fine-needle-aspiration-washout-samples-in-thyroid-nodules","Molecular Analysis Based on Fine-Needle Aspiration Washout Samples in Thyroid Nodules","","Molecular testing refines risk stratification for indeterminate thyroid nodules (Bethesda III–IV), yet evidence remains limited for dual-gene (BRAF and RAS) testing using fresh FNA washout specimens. A retrospective cohort evaluated BRAF/RAS mutation analysis from washout material, emphasizing indeterminate cytology. Among 1139 patients (307 with post-surgery histopathology), washout adequacy reached 90.9%. In operated cases, dual-gene testing showed 48.0% sensitivity, 89.6% specificity, and 72.9% accuracy under a borderline-benign assumption, with Bethesda III–IV results reflecting modest sensitivity and high specificity. The dual-gene approach was technically feasible (≥90.9% adequacy) and may support preoperative decision-making when comprehensive panels are unavailable.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/molecular-analysis-based-on-fine-needle-aspiration-washout-samples-in-thyroid-nodules/356284/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/molecular-analysis-based-on-fine-needle-aspiration-washout-samples-in-thyroid-nodules/356284.png","ImageObject",300,407,{"name":92,"@type":93},"Lucas Martin","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the study objective regarding thyroid nodules?","Question",{"text":113,"@type":114},"To evaluate the performance of BRAF and RAS mutation analysis using fresh FNA washout material, focusing on indeterminate (Bethesda III–IV) cytology.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How many patients and samples were analyzed, and how was adequacy assessed?",{"text":118,"@type":114},"The study retrospectively analyzed 1139 patients who underwent washout-based molecular testing; 1037/1139 samples (90.9%) provided adequate material for molecular analysis.",{"name":120,"@type":111,"acceptedAnswer":121},"What diagnostic performance did BRAF/RAS testing show for malignancy?",{"text":122,"@type":114},"Under a borderline/low-risk benign assumption, operated cases showed 48.0% sensitivity, 89.6% specificity, 75.9% PPV, 71.9% NPV, and 72.9% accuracy; Bethesda III–IV subset results showed 41.0% sensitivity, 85.2% specificity, and 66.0% accuracy with the malignant assumption.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},356284,1790381179,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Article  \nMolecular Analysis Based on Fine-Needle Aspiration Washout Samples in Thyroid Nodules  \nSevgül Fakı 1, *, Cevdet Aydın 2, ¸Sefika Burçak Polat 2, Gülsüm Karahmetli 1, Ahmet Cevdet Ceylan 3,  \nMustafa Altan 3, Ay¸segül Aksoy Altınbo ˘ga 4, Bülent Çomçalı 5, Oya Topalo ˘glu 2, Reyhan Ersoy 2 and Bekir Çakır 2  \nAcademic Editor: Maciej Wnuk  \nReceived: 23 December 2025  \nRevised: 13 January 2026  \nAccepted: 15 January 2026  \nPublished: 19 January 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Endocrinology and Metabolism, Ankara Bilkent City Hospital, Ankara 06800, Türkiye  \n2 Department of Endocrinology and Metabolism, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara 06010, Türkiye  \n3 Department of Medical Genetics, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara 06010, Türkiye  \n4 Department of Pathology, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara 06010, Türkiye  \n5 Department of General Surgery, Ankara Bilkent City Hospital, Ankara 06800, Türkiye  \n* [Correspondence: black_snowtr@yahoo.com](Correspondence: black_snowtr@yahoo.com); Tel.: +90-312-5526000-100562  \nAbstract  \nBackground: Molecular testing is recommended to refine risk stratification in indeterminate thyroid nodules (Bethesda III–IV), but data on dual-gene (BRAF and RAS) testing using fresh FNA washout specimens are limited. We aimed to evaluate the performance of BRAF and RAS mutation analysis from fresh thyroid FNA washout material, with a focus on indeterminate cytology. Methods: We retrospectively analyzed 1139 patients who underwent washout-based molecular testing between May 2022 and October 2024 at a tertiary endocrine center. Of these, 307 had available histopathologic results after surgery. Primary outcomes were sample adequacy, mutation spectrum, and diagnostic metrics (sensitivity, specificity, PPV, NPV, and accuracy) . Analyses were repeated under two assumptions that classified borderline/low-risk neoplasms as benign vs. malignant, and within the Bethesda III–IV subset. Results: Adequate material for molecular analysis was obtained in 1037/1139 samples (90.9%) . In the operated cohort (n = 307), malignant lesions comprised 31.9% and low-risk neoplasms 8.5% . When borderline lesions were considered benign, mutation positivity yielded a sensitivity of 48.0%, a specificity of 89.6%, a PPV of 75.9%, an NPV of 71.9%, and an accuracy of 72.9% . In Bethesda III–IV nodules (n = 153), sensitivity, specificity, and accuracy were 41.0%, 85.2%, and 66.0%(malignant assumption) . Isolated BRAF positivity showed high specificity (~96.7%) with modest sensitivity. Conclusions: Our findings extend current diagnostic approaches by showing that dual-gene (BRAF and RAS) testing from fresh FNA washouts is technically feasible (≥90% adequacy) and provides high specificity with modest sensitivity for malignancy in indeterminate nodules. In settings lacking comprehensive commercial panels, this lowcomplexity approach offers a practical adjunct to cytology and imaging for preoperative decision-making.  \nKeywords: thyroid nodule; indeterminate cytology; Bethesda III–IV; BRAF; RAS; FNA washout; molecular testing; diagnostic accuracy  \n1. Introduction  \nSince the 1980s, the worldwide occurrence of thyroid cancer has shown a remarkable upward trend, while death rates have remained largely unchanged. This discrepancy is  \nthought to stem mainly from the increased detection of small, slow-growing papillary thyroid tumors, a consequence of the expanding and occasionally unnecessary use of diagnostic imaging, particularly high-resolution thyroid and neck ultrasonography. In addition, a modest but genuine rise in the incidence of more advanced forms of thyroid cancer over recent decades has further contributed to the overall increase in reported ","cbCaiiBYkIiaBNGh","https://ap.wps.com/l/cbCaiiBYkIiaBNGh","pdf",425855,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# 1. Introduction","[{\"question\":\"What was the study objective regarding thyroid nodules?\",\"answer\":\"To evaluate the performance of BRAF and RAS mutation analysis using fresh FNA washout material, focusing on indeterminate (Bethesda III–IV) cytology.\"},{\"question\":\"How many patients and samples were analyzed, and how was adequacy assessed?\",\"answer\":\"The study retrospectively analyzed 1139 patients who underwent washout-based molecular testing; 1037/1139 samples (90.9%) provided adequate material for molecular analysis.\"},{\"question\":\"What diagnostic performance did BRAF/RAS testing show for malignancy?\",\"answer\":\"Under a borderline/low-risk benign assumption, operated cases showed 48.0% sensitivity, 89.6% specificity, 75.9% PPV, 71.9% NPV, and 72.9% accuracy; Bethesda III–IV subset results showed 41.0% sensitivity, 85.2% specificity, and 66.0% accuracy with the malignant assumption.\"}]","Molecular Analysis Based on Fine-Needle Aspiration Washout Samples in Thyroid Nodules | PDF",1790124409,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6966e561886fa224114ce5d22fdf11c4.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cf744209623416166e72a3b6a1dc6e62.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/be074b4afa7ed626d947a11e820a995d.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/42d5c2b5df16beeeb726dc1fce5eae9d.webp",980,1385]